The Pharmaceutical Outcomes & Policy Innovations (POPi) programme focuses on the study of drug therapy with the goal of improving human health and quality of life. POPi’s mission is to foster pharmaceutical policy innovation through proactive policy research, training and knowledge translation concerning the effectiveness, safety and cost management of prescription drugs.
The Centre for Molecular Medicine and Therapeutics (CMMT) is dedicated to the practice of world-class discovery research contributing to the fundamental knowledge in the determination and control of genetic susceptibility to disease.
The Centre for Molecular Medicine and Therapeutics (CMMT) is a synergistic group of scientists and researchers who share a strong sense of commitment to solve the many genetic questions surrounding human illness and well-being. Affiliated with the University of British Columbia and the Child & Family Research Institute, CMMT conducts discovery research and translates that research into effective clinical and therapeutic strategies to promote health. For more information, visit www.cmmt.ubc.ca.
The Child & Family Research Institute (CFRI) conducts discovery, clinical and applied research to benefit the health of children and families. It is the largest institute of its kind in Western Canada. There are 200 investigators affiliated with CFRI. More than 200 trainees, including graduate students and postdoctoral fellows, work at the institute.
CFRI works in close partnership with the University of British Columbia (UBC); BC Children’s Hospital and Sunny Hill Health Centre for Children, BC Women’s Hospital & Health Centre and BC Mental Health & Addiction Services, agencies of the Provincial Health Services Authority; and BC Children’s Hospital Foundation. CFRI has additional important relationships with British Columbia’s five regional health authorities and with B.C. academic institutions Simon Fraser University, the University of Victoria, the University of Northern British Columbia and the British Columbia Institute of Technology.
BC Children’s is British Columbia’s only pediatric hospital and home to many specialized pediatric services available nowhere else in the province, including BC’s trauma centre for children, pediatric intensive care, kidney and bone marrow transplants, open heart surgery, neurosurgery and cancer treatment. Sunny Hill Health Centre for Children is the provincial facility that offers specialized child development and rehabilitation services to children and youth. BC Children’s and Sunny Hill are agencies of the Provincial Health Services Authority.
Previously known as The Canadian Adverse Drug Reaction Monitoring Program (CADRMP), the new Med Effect Web site provides access to the latest advisories, warnings and recalls, issued by Health Canada concerning therapeutic drugs as well as other marketed health products. Michael Smith Foundation for Health Research.
The Michael Smith Foundation for Health Research (MSFHR) is the provincial support agency for health research in British Columbia. Established by the BC government in 2001, MSFHR is an independent, third party organization that works to develop BC as a leading force in health research.
Genome Canada is the primary funding and information resource related to genomics and proteomics in Canada. Genome Canada’s innovative business model is built on the premise of funding and managing large-scale and multidisciplinary, internationally peer-reviewed research projects and science and technology platforms.
Genome British Columbia is one of six Genome Canada centres across the country. By working collaboratively with all levels of government, universities and industry, Genome BC is the catalyst for a vibrant, genomics-driven life sciences cluster with far reaching social and economic benefits for the province and Canada.
The Canadian Institutes of Health Research (CIHR) is the Government of Canada’s agency responsible for funding health research in Canada. CIHR’s mandate is to “excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health-care system.”
The Canada Foundation for Innovation (CFI) is an independent corporation created by the Government of Canada to fund research infrastructure. The CFI’s mandate is to strengthen the capacity of Canadian universities, colleges, research hospitals, and non-profit research institutions to carry out world-class research and technology development that benefits Canadians.
The University of British Columbia (UBC) is one of Canada’s largest and most prestigious public research and teaching institutions and consistently ranks among the top 40 universities in the world. It offers a range of innovative undergraduate, graduate and professional programs in the arts, sciences, medicine, law, commerce and other faculties. UBC has particular strengths in biotechnology, ranks in the top 10 universities in North America and number one in Canada for commercializing research and for its patent activity in the life sciences.